These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2660037)

  • 1. Ovarian hyperstimulation syndrome: an update review.
    Golan A; Ron-el R; Herman A; Soffer Y; Weinraub Z; Caspi E
    Obstet Gynecol Surv; 1989 Jun; 44(6):430-40. PubMed ID: 2660037
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of ovarian hyperstimulation syndrome.
    Amso NN; Shaw RW; Ahuja KK; Morris N
    Fertil Steril; 1991 Jan; 55(1):220-1. PubMed ID: 1986965
    [No Abstract]   [Full Text] [Related]  

  • 3. Ultrasonically guided vaginal aspiration of ascites in the treatment of severe ovarian hyperstimulation syndrome.
    Aboulghar MA; Mansour RT; Serour GI; Amin Y
    Fertil Steril; 1990 May; 53(5):933-5. PubMed ID: 2185045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute hydrothorax as the only symptom of ovarian hyperstimulation syndrome.
    Jewelewicz R; Vande Wiele RL
    Am J Obstet Gynecol; 1975 Apr; 121(8):1121. PubMed ID: 1119510
    [No Abstract]   [Full Text] [Related]  

  • 5. Accidental hyperstimulation during ovulation induction.
    Salat-Baroux J; Antoine JM
    Baillieres Clin Obstet Gynaecol; 1990 Sep; 4(3):627-37. PubMed ID: 2282745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian hyperstimulation: actual and theoretical risks.
    Smith BH; Cooke ID
    BMJ; 1991 Jan; 302(6769):127-8. PubMed ID: 1995129
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of ovarian hyperstimulation syndrome with chlorpheniramine maleate, mannitol, and invasive hemodynamic monitoring.
    Kirshon B; Doody MC; Cotton DB; Gibbons W
    Obstet Gynecol; 1988 Mar; 71(3 Pt 2):485-7. PubMed ID: 3126472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial.
    Palomba S; Falbo A; Di Cello A; Cappiello F; Tolino A; Zullo F
    Fertil Steril; 2011 Nov; 96(5):1128-33. PubMed ID: 21917254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of ovulation induction with gonadotrophins on the ovary and uterus and implications for assisted reproduction.
    Balen A
    Hum Reprod; 1995 Sep; 10(9):2233-7. PubMed ID: 8530642
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe ovarian hyperstimulation syndrome using agonists of gonadotropin-releasing hormone for in vitro fertilization: a European series and a proposal for prevention.
    Forman RG; Frydman R; Egan D; Ross C; Barlow DH
    Fertil Steril; 1990 Mar; 53(3):502-9. PubMed ID: 2106456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between peak estradiol levels and ovarian torsion among symptomatic patients receiving gonadotropin treatment.
    Romanski PA; Melamed A; Elias KM; Stanic AK; Anchan RM
    J Assist Reprod Genet; 2017 May; 34(5):627-631. PubMed ID: 28299550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous bilateral ovarian torsion in the follicular phase after gonadotropin stimulation.
    Kang HJ; Davis OK; Rosenwaks Z
    Fertil Steril; 2006 Aug; 86(2):462.e13-4. PubMed ID: 16806209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian hyperstimulation: diagnosis and therapy.
    Cianci A; Roccasalva L; Agnello C; Riillo S; Palumbo G
    Acta Eur Fertil; 1989; 20(6):373-5. PubMed ID: 2488984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Avoidance of cancellation of potential hyperstimulation cycles by conversion to in vitro fertilization-embryo transfer.
    Lessing JB; Amit A; Libal Y; Yovel I; Kogosowski A; Peyser MR
    Fertil Steril; 1991 Jul; 56(1):75-8. PubMed ID: 1906019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dosing of gonadotropins in in vitro fertilization cycles for women with poor ovarian reserve: systematic review and meta-analysis.
    Youssef MA; van Wely M; Mochtar M; Fouda UM; Eldaly A; El Abidin EZ; Elhalwagy A; Mageed Abdallah AA; Zaki SS; Abdel Ghafar MS; Mohesen MN; van der Veen F
    Fertil Steril; 2018 Feb; 109(2):289-301. PubMed ID: 29317127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of poor ovarian response to initial gonadotropin stimulation.
    Keay SD; Jenkins JM
    Fertil Steril; 2005 Dec; 84(6):1797; author reply 1797-8. PubMed ID: 16359996
    [No Abstract]   [Full Text] [Related]  

  • 17. [Poor ovary response to the controlled ovarian hyperstimulation].
    Vladimirov IaK; Blagoeva V
    Akush Ginekol (Sofiia); 2003; 42(6):25-8. PubMed ID: 15067811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian hyperstimulation syndrome: a current survey.
    Schenker JG; Weinstein D
    Fertil Steril; 1978 Sep; 30(3):255-68. PubMed ID: 361440
    [No Abstract]   [Full Text] [Related]  

  • 19. Does salpingectomy affect the ipsilateral ovarian response to gonadotropin during in vitro fertilization-embryo transfer cycles?
    Orvieto R; Saar-Ryss B; Morgante G; Gemer O; Anteby EY; Meltcer S
    Fertil Steril; 2011 Apr; 95(5):1842-4. PubMed ID: 21185019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.